Dmytro Kharkov

Injective climbs 2.27% amid oversold RSI and continued seller control – weekly analysis

Injective climbs 2.27% amid oversold RSI and continued seller control – weekly analysis
Injective gains 2.27% this week

Injective (INJ) closed the week at $3.07, gaining 2.27% from the previous week in a volatile session that saw heightened price swings of 28.22%. The asset remains well below its weekly moving averages — MA-20 at $5.05, MA-50 at $9.11, and MA-200 at $12.91 — underscoring ongoing downward momentum and persistent selling pressure.

INJ price prediction
24H 0.72%
$4.2
48H -3.12%
$4.04
7D -22.3%
$3.24
1M 11.51%
$4.65
3M 150.36%
$10.44
6M 118.23%
$9.1
12M 97.12%
$8.22
Current price: $ 4.17 -0.12 2.89%
Real-time Data 14:03
Daily range 4.1 Arrow from to Icon 4.32
Weekly range 4.13 Arrow from to Icon 5.41
Loading...

Highlights

  • INJ trades significantly below key moving averages, indicating sustained bearish momentum and selling pressure across all timeframes.
  • Bearish technical signals predominate, with momentum and trend indicators showing oversold conditions and negligible probability of a near-term bullish breakout.
  • INJ is expected to remain volatile within a $2.40 to $3.70 range in the coming week, with downside risk prevailing.

Technical weakness sustains as bearish signals overwhelm oversold readings

Weekly technicals continue to signal weakness for INJ. Bearish momentum dominates, as the MACD and ADX both issue Sell signals and the price lags all three major weekly moving averages. Oscillators such as the RSI and CCI reflect oversold conditions and strong seller control, while Bull/Bear Power remains deeply negative. Stochastic RSI and the Hull Moving Average point to potential short-term buy interest, but the Awesome Oscillator is neutral and overall indicator agreement is lacking.

Injective asset chart
Injective price dynamics. Source: TradingView.

Bearish risks dominate next week as sideways range and low breakout odds persist

For the upcoming week, INJ is expected to trade within the $2.40 to $3.70 range, consistent with its current volatility and weak technical backdrop. The likelihood of a decisive bullish breakout is low, with less than a 20% probability, as zero core momentum and trend indicators present a Buy or Strong Buy signal. The base case remains for sideways movement within this corridor, with bearish risks dominating and a possible move toward $2.40 if negative momentum persists. Only an unexpected surge in buying interest could push a rebound toward $3.70 resistance.

Parshwa Turakhiya, analyst, notes that Injective (INJ) ended the week with slight gains but remains in a broad downtrend, trading well below all its major moving averages. He sees overall sentiment as negative, with technical signals showing firm seller control and little case for an imminent reversal. With a lack of bullish momentum and almost all major indicators pointing to continued weakness, Turakhiya believes the base case is for INJ to move sideways within the $2.40 to $3.70 corridor over the coming week. Only a strong shift in sentiment or clear buying pressure could test the upper end of this range. "Despite minor rebounds, I’m not chasing upside until momentum and indicators turn — for now, the setup favors caution and range trading around support," he says.

Previously it was reported that Injective is trading below key moving averages across all timeframes amid persistent selling pressure, with momentum indicators such as the MACD, ADX, and Awesome Oscillator confirming a negative trend and weak momentum while support holds just above the recent intraday low. Immediate resistance is noted at the Ichimoku Kijun, and while institutional inflows and increased trading volume mark heightened activity, the likelihood of continued downside and sideways price action remains high.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.